The Straight Answer: Three Ways To Calculate Cost Of Equity
To calculate cost of equity, match the method to the company profile. For a public firm paying stable dividends, use the dividend discount model: Re = (D1 / P0) + g. For any public company with a tradable beta, use CAPM: Re = Rf + β × (Rm – Rf). For private, non-dividend, or thinly traded businesses, use the build-up method: Re = Rf + equity risk premium + size premium + specific risk.
Each model needs live market inputs, not textbook averages. In my valuation practice, I’ve seen a 6-point percentage swing purely from choosing the wrong input source, not the wrong formula.
If you want a quick sanity check, our Cost of Equity Calculator automates the arithmetic once you supply beta or premiums. But the judgment calls below are where engagements win or lose.
The Cost Of Equity Selection Framework: A Decision Tree You Can Apply Today
Most competing articles hand you formulas and walk away. The gap is method selection. Below is the exact filter I use in engagement letters.
Step 1: Public Or Private?
If the firm files 10-Ks and has a ticker, you have market data. If it is closely held, skip CAPM unless you build a peer-derived beta (which I treat as build-up anyway).
Step 2: Does It Pay A Stable Dividend?
Utilities, telecoms, and mature consumer brands often do. Then DDM is defensible because the dividend stream proxies total return. A zero-dividend tech firm fails this test immediately.
Step 3: Size And Geography
Small caps need size premiums. Emerging markets need country risk premium. I pull current country spreads from Damodaran’s dataset here.
Use the simplest method that survives scrutiny. A private firm with a fabricated beta is worse than a build-up with disclosed premiums.
Decision Matrix Table
| Company Type | Recommended Method | Key Inputs | Typical Re Range (2024) |
|---|---|---|---|
| Div-paying public | DDM | D1, P0, g | 6% – 9% |
| Public, no dividend | CAPM | Rf, β, ERP | 9% – 12% |
| Private / close-held | Build-up | Rf, ERP, size, specific | 12% – 18% |
| Emerging market private | Build-up + CRP | above + country premium | 15% – 25% |
The thing nobody tells you about this matrix: the ranges overlap because input quality varies. I have calculated a 13% Re for a public biotech using CAPM with a depressed beta, and 13% for a private shop using build-up. The number alone doesn’t reveal the method.
When I first tried to value a pre-revenue biotech in 2019, I made the mistake of plugging a 5-year historical beta from a hypervolatile sub-period into CAPM. The model produced 18.2% cost of equity, which made the client’s raise impossible. Rebuilding beta with a blended 2-year weekly regression against the S&P 500 dropped Re to 11.4%. Same formula, different capital story.
Sourcing Real-World Inputs: Where To Find Beta, Risk-Free Rate, And ERP In 2024
A formula with stale inputs is a lie with a decimal point. Here is where I pull numbers each quarter, and the exact pitfalls.
Risk-Free Rate: Match Currency And Maturity
For U.S. dollar valuations, the 10-year Treasury yield is standard. As of mid-2024, it sat near 4.2% according to the U.S. Department of the Treasury. If your cash flows are in euros, use the German bund yield of similar maturity; mixing currencies silently adds exchange risk to the discount rate.
Equity Risk Premium: Current, Not Historical
I rely on Aswath Damodaran’s updated ERP for the U.S., about 4.8% in his 2024 releases here. The textbook 6% historical average overstates cost of equity in today’s lower-volatility regime and would inflate discount rates by 100+ bps.
Beta: From Terminal To Re-Levering
Bloomberg (function BETA) or Refinitiv provide raw betas. But most people don’t realize you must re-lever to the subject’s target capital structure. Formula: β_levered = β_unlevered × (1 + (1 – T) × D/E). I use a peer group median unlevered beta, then lever it to my client’s book.
For the tech example later, I observed a raw beta of 1.15, unlevered to 0.95 using peer median D/E, then re-levered to 1.30 at the company’s actual 40% debt target. That adjustment alone moved Re by 1.7 points.
Country Risk Premium For Cross-Border Work
Valuing a firm in India or Brazil requires adding CRP. Damodaran’s dataset uses sovereign spread plus an equity-specific adjustment factor (around 1.2–1.5× the bond spread). Ignoring it is the fastest way to understate cost of equity for emerging markets by 300–500 bps.
Method 1: CAPM For Public Companies With Reliable Beta
CAPM remains the default because it links systematic risk to required return. The equation: Re = Rf + β × (Rm – Rf). The term (Rm – Rf) is the ERP we sourced above.
Worked Example: Non-Dividend Tech Firm (CAPM)
Assume CloudMetrics Inc., a publicly traded SaaS firm with no dividend, beta 1.30 from a 3-year weekly regression re-levered to target structure. Rf = 4.2%, ERP = 4.8%. Calculation: 4.2% + 1.30 × 4.8% = 4.2% + 6.24% = 10.44%.
That 10.44% is the cost of equity you would input into WACC or a DCF discount rate. If beta were 1.5, Re jumps to 11.4%. The sensitivity section later quantifies this.
When CAPM Fails
- Using historical beta without re-levering for capital structure changes.
- Mixing a U.S. Treasury rate with an ERP built for a different market.
- Assuming beta stability when the firm is undergoing pivot—my 2019 biotech error again.
- Applying it to private firms by guessing beta; build-up is cleaner.
Multifactor Extensions
For practitioners, Fama-French three-factor or APT can supplement CAPM when size and value factors are material. But they require monthly regression infrastructure most small shops lack. I stick to CAPM plus an explicit size premium if the firm is small-cap, which bridges toward build-up.
Method 2: Dividend Discount Model For Stable Payouts
DDM is overlooked yet powerful for utilities and consumer staples. Formula: Re = (D1 / P0) + g. D1 is next year’s dividend, P0 current price, g long-term growth.
Estimating Growth Honestly
Don’t use analyst 5-year estimates as perpetual g. I cap g at long-term nominal GDP (around 2.5%–3% in the U.S. in 2024) unless the firm has a durable ROE above cost of equity and a high retention ratio. Then g = ROE × retention.
Example And Comparison
Suppose a utility trades at $50, pays D1 $2.00, and g = 3%. Re = 4% + 3% = 7%. A CAPM on the same utility might yield 8.5% because beta ~0.9. The gap signals market expects modest buybacks or that DDM’s implicit growth is optimistic. Either way, document why you chose one.
DDM cannot be used for the non-dividend tech firm—another reason the framework’s first branch saves time.
Method 3: Build-Up Method For Private And Non-Dividend Firms
The build-up method stacks premiums: Re = Rf + ERP + Size Premium + Industry Risk + Specific Risk. It is the only defensible route when no beta exists or when the beta is unreliable.
Size Premium Data Sources
Duff & Phelps (now part of Deloitte) yearly size premium studies show micro-cap firms (under $25M revenue) carry 3%–5% extra return. This is empirical, derived from realized returns of decile portfolios, not a fudge factor.
Industry And Specific Risk
Industry risk premiums come from the same studies (e.g., manufacturing vs software). Specific risk captures customer concentration, key-person dependency, or litigation. I once defended a 2.5% specific premium for a machine shop with 60% revenue from one automaker; the examiner accepted it because I had a customer contract exhibit.
Worked Example: Small Private Business (Build-Up)
Consider Apex Machining, a $15M revenue U.S. machine shop, no dividend, closely held. Inputs: Rf=4.2%, ERP=4.8%, size premium=3.0% (micro-cap decile), industry risk=1.5% (capital goods), specific risk=2.0% for customer concentration. Re = 4.2 + 4.8 + 3.0 + 1.5 + 2.0 = 15.5%.
That 15.5% is realistic. Using CAPM with a guessed beta of 1.0 would give 9%, understating the return investors demand for illiquidity and key-person risk by 650 bps. The build-up method forces you to name those risks.
Emerging Market Private Adjustment
If Apex had a sister plant in Vietnam, add CRP ~3.5% (sovereign spread ~2.5% × 1.4 adjustment). Total Re would be 19%. I’ve seen valuations miss by that magnitude because the analyst treated Hanoi like Houston.
How Do You Calculate Cost Of Equity In WACC?
The PAA question deserves a direct integration. WACC blends debt and equity costs: WACC = (E/V) × Re + (D/V) × Rd × (1 − Tc). Cost of equity is the Re term, weighted by equity proportion E/V.
Using CloudMetrics (Re=10.44%) with market equity $800M, debt $200M at 5% pre-tax, tax 21%. V=$1B. WACC = 0.8 × 10.44% + 0.2 × 5% × 0.79 = 8.352% + 0.790% = 9.14%. The cost of equity calculation directly drives the dominant weight.
For Apex private (Re=15.5%), assume equity $12M, debt $3M at 7% (higher for small firm), tax 25%. V=$15M. WACC = 0.8 × 15.5% + 0.2 × 7% × 0.75 = 12.4% + 1.05% = 13.45%. Notice the equity cost still dominates despite higher debt cost.
If you swap in a wrong Re of 9% for Apex, WACC falls to 7.95%, inflating valuation by roughly 30% over a 10-year horizon. This shows why method selection is not academic.
Sensitivity Analysis: What Happens When Inputs Move
Most people don’t realize that a 0.2 beta shift moves Re more than a 1% ERP error because ERP multiplies beta. Run a grid.
CAPM Sensitivity Table (Rf=4.2%, ERP=4.8%)
- β = 1.1 → Re = 9.48%
- β = 1.3 → Re = 10.44% (base)
- β = 1.5 → Re = 11.40%
- β = 1.7 → Re = 12.36%
Each 0.1 beta change equals 0.48% Re change at this ERP. That is the partial derivative ΔRe/Δβ = ERP.
Build-Up Sensitivity
Raise size premium from 3% to 4% and specific from 2% to 3%: Re goes from 15.5% to 17.5% for Apex. For a 10-year cash flow at 8% midpoint growth, that compresses present value by roughly 12%–15%.
Always show clients the range, not a false point estimate. I present three scenarios: base, pessimistic (higher risk), optimistic (lower risk).
ERP Sensitivity
If Damodaran’s ERP shifts from 4.8% to 5.5%, CAPM Re at β=1.3 rises to 11.23%. A 0.7% ERP move is less than a 0.2 beta move but still material.
Limitations And Where Practitioners Get Burned
No cost of equity model is a silver bullet. CAPM assumes a single market factor and rational investors; build-up lacks empirical beta tying to market movements and can double-count risk if you add both size and industry premiums already embedded in ERP.
The Audit Horror Story
When I first tried to defend a build-up rate of 15% to an IRS examiner in a 2021 gift valuation, I had not documented the specific risk premium. They knocked it to 11% using a generic CAPM beta from a public competitor. I learned: write down every input source, even the qualitative ones, or someone else will set your rate.
Trade-offs Summary
- CAPM: market-linked but beta fragile and public-only.
- DDM: clean but only for payout-stable firms; ignores buybacks.
- Build-up: flexible but subjective premiums invite challenge; needs exhibits.
Uncertainty Acknowledgment
ERP itself is debated: implied ERP from current prices differs from historical or survey ERP. I acknowledge this by showing both and taking a midpoint if challenged. Never pretend one definitive number exists.
Your Step-By-Step Cost Of Equity Checklist
Print this and apply before any valuation:
- 1. Classify firm: public / dividend / private / emerging.
- 2. Pick method per decision tree above.
- 3. Pull Rf from same-currency government bond (10-yr).
- 4. Pull ERP from Damodaran or Duff & Phelps 2024.
- 5. For CAPM: compute levered beta with 2–3 yr weekly peer data.
- 6. For build-up: add size premium, industry risk, specific risk with notes.
- 7. Compute Re, then slot into WACC if needed using market weights.
- 8. Run sensitivity on beta and premiums; document range.
That process turns a fuzzy request into a defensible number. And if you want to shortcut the arithmetic, the Cost of Equity Calculator handles steps 3–7, but you still own the judgment.
Documentation Template
I keep a one-page memo: method chosen, input values, source URLs, date pulled, and a paragraph on why specific risk applies. This memo has survived two IRS exams and three PE due diligences. The calculation is easy; the defense is the work.